No Data
No Data
Curve Therapeutics Further Strengthens Leadership Team With the Appointment of Andre Hoekema as New Chair of Board
Excellos, Cell Therapy Contract And Development Manufacturing Organization Member Of Blood Centers Of America Has Been Selected To Manufacture Galapagos' Car-t Cell Therapy Candidate, GLPG5101, For Its Recently FDA-Cleared ATALANTA-1 Study For...
Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos' CAR-T Cell Therapy Clinical Study Close to Cancer Treatment Centers in the San Diego Area
Record Galapagos Debt-for-nature Swap Scrutinized Over Transparency Irregularities Claims
Morgan Stanley Reaffirms Their Hold Rating on Galapagos (GLPG)
Galapagos Announces Major Stake by EcoR1 Capital